Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 7403519922
Scopus Author ID: 57685821800

Activities

Collapse all

Employment (7)

University of Edinburgh: Edinburgh, Edinburgh, GB

2017-07-01 to present | Head of Centre for Cardiovascular Science (Centre for Cardiovascular Science)
Employment
Source: Self-asserted source
Andrew Baker

University of Edinburgh: Edinburgh, Edinburgh, GB

2016-02-01 to present | Gustav Born Chair of Vascular Biology. (Centre for Cardiovascular Science)
Employment
Source: Self-asserted source
Andrew Baker

University of Edinburgh: Edinburgh, Edinburgh, GB

2015-10-01 to present | BHF Chair of Translational Cardiovascular Sciences (Centre for Cardiovascular Science)
Employment
Source: Self-asserted source
Andrew Baker

University of Glasgow: Glasgow, Glasgow, GB

2011-11-01 to 2015-09-30 | Deputy Director, Institute of Cardiovascular & Medical Sciences,
Employment
Source: Self-asserted source
Andrew Baker

University of Glasgow: Glasgow, Glasgow, GB

2011-08-01 to 2015-09-30 | BHF Chair Professor of Translational Cardiovascular Sciences,
Employment
Source: Self-asserted source
Andrew Baker

University of Glasgow: Glasgow, Glasgow, GB

2010-08-01 to 2011-10-31 | Acting Director, Institute of Cardiovascular & Medical Sciences,
Employment
Source: Self-asserted source
Andrew Baker

University of Glasgow: Glasgow, Glasgow, GB

2005-02-01 to 2011-07-31 | Professor of Molecular Medicine,
Employment
Source: Self-asserted source
Andrew Baker

Education and qualifications (6)

Academy of Medical Sciences: London, GB

2015 to present | FMedSci
Education
Source: Self-asserted source
Andrew Baker

Royal Society of Edinburgh: Edinburgh, GB

2010 to present | FRSE
Qualification
Source: Self-asserted source
Andrew Baker

European Society of Cardiology: Sophia Antipolis, PACA, FR

2007 to present | FESC
Education
Source: Self-asserted source
Andrew Baker

American Heart Association Inc: Dallas, TX, US

2002 to present | FAHA (International Fellow of the American Heart Association)
Education
Source: Self-asserted source
Andrew Baker

University of Wales College of Medicine: Cardiff, GB

1990 to 1994 | PhD (College of Medicine)
Education
Source: Self-asserted source
Andrew Baker

University of London: London, London, GB

1986 to 1990 | BSc (Joint Hons) (Pharmacology and Toxicology.)
Education
Source: Self-asserted source
Andrew Baker

Professional activities (6)

British Society for Gene and Cell Therapy: Oxford, GB

President
Membership
Source: Self-asserted source
Andrew Baker

Chinese University of Hong Kong: New Territories, HK

2017 to present | Visiting Professor
Invited position
Source: Self-asserted source
Andrew Baker

Maastricht University: Maastricht, Limburg, NL

2016 to present | Visiting Professor:
Invited position
Source: Self-asserted source
Andrew Baker

MRC DPFS: London, GB

2012 to 2018 | Panel Member
Membership
Source: Self-asserted source
Andrew Baker

UK Gene Therapy Advisory Committee,: London, GB

2005 to 2013 | Panel Member
Membership
Source: Self-asserted source
Andrew Baker

American Society of Gene Therapy and Cell Therapy: Milwaukee, Wisconsin, US

2004 to 2008 | Committee member
Membership
Source: Self-asserted source
Andrew Baker

Funding (12)

CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

2019 to 2023 | Grant
European Commission (European Commission, GB)
Source: Self-asserted source
Andrew Baker

BHF Centre for Vascular Regeneration,

2017 to 2021 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

BHF Chair of Translational Cardiovascular Sciences renewal,

2016 to 2019 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

Role of non-coding RNA in vascular pathology

2015 to 2019 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

HF UK Cardiovascular Regenerative Medicine Centre

2015 to 2017 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

ERC Advanced Grant, (VASCMIR)

2014 to 2019 | Grant
European Research Council (Brussels, BE)
Source: Self-asserted source
Andrew Baker

Adenovirus vector technology: next generation systems for medical therapy technology (ADVEC), FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP),

2013 to 2017 | Grant
European Commission (European Commission, GB)
Source: Self-asserted source
Andrew Baker

BHF 4 year PhD studentship programme

2013 to 2017 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

Adenovirus serotype 49: a novel vector for vascular gene therapy

2012 to 2016 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

Translating Human Embryonic Stem Cell-Derived Endothelial Cell Therapy to the Clinic

2012 to 2015 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Andrew Baker

BHF Chair of Translational Cardiovascular Sciences,

2011 to 2016 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

Integrating virology and vascular biology: development and evaluation of the next generation systems for genetic manipulation of the vessel wall,

2010 to 2015 | Grant
British Heart Foundation (London, GB)
Source: Self-asserted source
Andrew Baker

Peer review (1 review for 1 publication/grant)

Review activity for Nature communications (1)
How many people are using ORCID?